One of MicroMol's earliest funded research activities was focussed on the determination and interference in abnormalities of the human immune system, especially in autoimmune disease and allergy. In this area 4 projects were funded by the authorities:
The goal of the DiaTRAK project was the development of an innovative technology for the diagnosis of TSH receptor dependent autoimmune disease. As a result of this project a preliminary test system based on recombinant TSHR variants was established with which it was possible to determine anti-TSHR reactivity from the serum of patients suffering from thyroid autoimmune disease.
During the course of the TheraTRAK project 3 physiologically relevant autoantibody epitopes of the human TSH receptor which might be basis for a novel therapeutical approach for the treatment of autoimmune diseases of the thyroid could be evaluated.
__________
__________
The AllergoScan and the AllergoDiff projects, granted either by the initiative Biotechnology Baden Württemberg or the KMU-INNOVATIV initiative respectively, focussed on the development of a highly specific method for the determination of hidden food allergens in defined food samples and/or directly in the production line of food producing facilities. Hereby the focus is directed onto celery as one of the most powerful food allergens known to date. ALLERGODIFF was carried out in cooperation with R-biopharm AG, aimed to specify celery reactivities and to transform research results in a real test formate.
__________
__________
Two recent highly innovative research projects granted by the authorities (BMWT and BMBF) focus on the infection and infection prevention of zoonotic pathogens like Salmonella and Campylobacter spec. In this regard MicroMol established a unique panel of chicken enterocyte cell lines to create the perfect environment to analyze the infection of these zoonotic pathogens. During the course of these projects it is planned to establish in vitro test systems which mimick the natural infection process and will be an optimal basis to evaluate inhibitors of the infection process.
__________
__________
Products, achievements and services are open to the scientific community and the customer. MicroMol is looking forward to your contact!